Evidence map›Paper›PMID 41972192›Full record

ArticleToxicology reports2026

Safety evaluation of an effervescent curcuminoids-ascorbic acid-polysaccharide-β-cyclodextrin (CUR-A-Poly-β-CD) inclusion complex powder in healthy volunteers: A non-placebo-controlled pilot study.

Chanatip Pramvichai, Wariya Mongkolwat, Siripat Aluksanasuwan, Wuttichai Jaidee, Rawiwan Charoensup, Siriwan Pimtong, Benjamaporn Chearmuangphan, Artitaya Rongjumnong, Arunothai Wanta, Atthapan Morchang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chanatip PramvichaiSchool of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Wariya MongkolwatCancer and Immunology Research Center (CIRC), Mae Fah Luang University, Chiang Rai 57100, Thailand.
Siripat AluksanasuwanSchool of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Wuttichai JaideeMedicinal Plants Innovation Center of Mae Fah Luang University, Chiang Rai 57100, Thailand.
Rawiwan CharoensupMedicinal Plants Innovation Center of Mae Fah Luang University, Chiang Rai 57100, Thailand.
Siriwan PimtongMae Fah Luang University Medical Center Hospital, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Benjamaporn ChearmuangphanMae Fah Luang University Medical Center Hospital, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Artitaya RongjumnongSchool of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Arunothai WantaSchool of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Atthapan MorchangSchool of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand.
Keerakarn SomsuanSchool of Medicine, Mae Fah Luang University, Chiang Rai 57100, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is a prevalent and aggressive malignancy with a high mortality rate. Although chemotherapy can improve survival outcomes, it is frequently associated with undesirable side effects. Curcuminoids, the principal polyphenol derived from

Indexed as

Colorectal cancerCurcuma longa L.CurcuminHealthy volunteersSafety evaluation

Identifiers

PMID41972192
PMCPMC13068598

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.